Skip to main content

Navigation group

Type at least 3 characters
1,057 articles

Articles

Original Research

Published on 06 Jul 2022

Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is Correlated With Fibroblast Growth Factor 23: Sub-Analysis Results of the ETACAR-HD Study

in Nephrology

  • Katharina Dörr
  • Sebastian Hödlmoser
  • Michael Kammer
  • Roman Reindl-Schwaighofer
  • Matthias Lorenz
  • Bianca Reiskopf
  • Rahel Jagoditsch
  • Rodrig Marculescu
  • Rainer Oberbauer
Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is Correlated With Fibroblast Growth Factor 23: Sub-Analysis Results of the ETACAR-HD Study
Frontiers in Medicine
doi 10.3389/fmed.2022.948177
  • 2,328 views
  • 4 citations